Harvard Bioscience (HBIO) Debt Ratio (2010 - 2026)

Harvard Bioscience (HBIO) has 17 years of Debt Ratio data on file, last reported at 0.46 in Q1 2026.

• On a quarterly basis, Debt Ratio rose 3.11% year-over-year to 0.46 in Q1 2026; TTM through Mar 2026 was 0.46, a 3.11% increase from a year earlier, with the FY2025 full-year figure at 0.45, up 53.52% from the prior year.
• Debt Ratio for Q1 2026 stood at 0.46, up from 0.45 in the prior quarter.
• Over the last five years, Debt Ratio for HBIO reached as high as 0.46 in Q1 2026 and fell as low as 0.27 in Q1 2024.
• Historically, Debt Ratio has averaged 0.35 across 5 years, with a median of 0.32 in 2023.
• Across the five-year window, Debt Ratio fell 17.24% in 2023 and jumped 68.5% in 2025, its largest moves.
• Year by year, Debt Ratio stood at 0.32 in 2022, then declined by 4.13% to 0.31 in 2023, then retreated by 5.51% to 0.29 in 2024, then surged by 53.52% to 0.45 in 2025, then rose by 3.71% to 0.46 in 2026.
• Per Business Quant data, the three most recent Debt Ratio figures were 0.46 in Q1 2026, 0.45 in Q4 2025, and 0.44 in Q3 2025.